Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNC006197

Drug Information
IndicationNot AvailableExperimental    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCOC1=CC=C(C=C1)C2=C(C(=O)NC2=O)C3=CC=CC=C3    
TargetCyclin-dependent kinase 1Inhibitor[1]
Cyclin-dependent kinase 2Inhibitor[1]
Cyclin-dependent kinase 4Inhibitor[1]
Cyclin-dependent kinase 6Inhibitor[1]
Epidermal growth factor receptor erbB1Inhibitor[1]
G1/S-specific cyclin D1Inhibitor[1]
G1/S-specific cyclin E2Inhibitor[1]
G2/mitotic-specific cyclin B1Inhibitor[1]
Protein kinase C alpha Inhibitor[1]
Protein kinase C epsilonInhibitor[1]
Protein kinase C gammaInhibitor[1]
Receptor protein-tyrosine kinase erbB-2Inhibitor[1]
Tyrosine-protein kinase TIE-2Inhibitor[1]
Vascular endothelial growth factor receptor 2Inhibitor[1]
Ref 1J Med Chem. 2006 Feb 23;49(4):1271-81.Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543